New Delhi: Covid-19 vaccine Covovax is on the market for everybody above the age of 12 years, CEO of Serum Institute of India’s (SII) Adar Poonawalla stated on Wednesday. Earlier, on Tuesday, Poonawalla had stated that kids aged 12 to 17 years in India can now get SII’s Covovax and hailed Prime Minister Narendra Modi for his imaginative and prescient in offering one other vaccine for youngsters.
Taking to his Twitter deal with, Poonawalla stated, “A variety of you might have requested if Covovax is on the market for adults. The reply is sure, it’s out there for everybody above the age of 12.”
A variety of you might have requested if Covovax is on the market for adults. The reply is sure, it’s out there for everybody above the age of 12.
— Adar Poonawalla (@adarpoonawalla) May 4, 2022
Earlier, he had tweeted, “Covovax (@Novavax) is now out there for youngsters in India. That is the one vaccine manufactured in India that can be offered in Europe and has an efficacy of > 90%. That is in step with Shri @narendramodi Ji’s imaginative and prescient of offering yet one more vaccine to guard our youngsters.”
It’s to be famous that the Nationwide Technical Advisory Group on Immunisation (NTAGI) on Friday had authorized Serum Institute of India’s Covid-19 vaccine Covovax for the 12-17 yr age group, sources near information company IANS stated.
India’s drug regulator, the Medication Controller Normal of India (DCGI) had authorized the vaccine for the restricted use in emergency conditions in adults on December 28 final yr and within the 12-17 age group with sure circumstances on March 9.
Covovax is the second Covid-19 vaccine manufactured by the SII, which makes the Covishield vaccine, the dose that’s most generally used within the nation.
(With inputs from companies)